PR Newswire#pr
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Resultstranslating…
1h agoFactuality: 70/100USACision
Veris Health accelerated its commercial engagement with OSU-The James Veris Health implantable physiological monitor achieved development milestones towards upcoming FDA submission Lucid Diagnostics secured first laboratory benefit manager coverage policy for EsoGuard ®…